Literature DB >> 26447417

Avascular Necrosis of Trochlea After Supracondylar Humerus Fractures in Children.

Brian E Etier, J Scott Doyle, Shawn R Gilbert1.   

Abstract

Avascular necrosis (AVN) is a rare but important complication after supracondylar humerus fractures. Posttraumatic humerus deformity was first reported in 1948 and sporadically thereafter. AVN deformity has been classified as type A (AVN of the lateral ossification center) and type B (AVN of the entire medial crista and a metaphyseal portion). In this article, we present 5 cases of AVN after supracondylar humerus fracture, discuss the importance of late clinical findings, and postulate a mechanism of AVN in nondisplaced fractures. Five cases of AVN after supracondylar humerus fracture were reviewed from the Children's of Alabama database. Four of the 5 patients were female. Four patients sustained a Gartland type III fracture, and 1 patient sustained a nondisplaced Gartland type I fracture. Age at time of injury ranged from 5 years to 10 years. All patients had an asymptomatic clinical period after treatment and re-presented 6 months to 7 years later with elbow pain or loss of motion. All patients were treated symptomatically. AVN of the trochlea has a late clinical presentation. The cause of this complication is interruption of the trochlea blood supply. In displaced fractures, the medial and/or lateral vessels are injured, leading to type A or type B deformity. In nondisplaced fractures, the lateral vessels are interrupted by tamponade because of encased fracture hematoma; this presents as a type A deformity. Both type A and type B deformities can be clinically significant. AVN of the trochlea should be considered in patients with late presentation of pain or loss of motion after treatment of supracondylar humerus fractures.

Entities:  

Mesh:

Year:  2015        PMID: 26447417

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  1 in total

1.  Post-traumatic disturbance of the epiphysis of the humeral trochlea: a spectrum of pathology.

Authors:  Femke M A P Claessen; Suzanne de Vos-Jakobs; Michel P J van den Bekerom; Taco Gosens; Denise E Eygendaal
Journal:  JSES Int       Date:  2020-08-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.